Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (171-180 of 328) with videos related to

Pageof 33
Sort By:
Annals of Surgical Oncology|March 24, 2018
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal AdenocarcinomaLucas Goense, Peter S N van Rossum, Mian Xi, et al.
Translational Lung Cancer Research|February 10, 2023
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancerEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation TherapyXin Wang, Peter S N van Rossum, Yan Chu, et al.
Cancer Immunology Research|June 13, 2019
An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune ResponsesIsmail M Meraz, Mourad Majidi, Feng Meng, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2013
Predictors of postoperative complications after trimodality therapy for esophageal cancerJingya Wang, Caimiao Wei, Susan L Tucker, et al.
International Journal of Particle Therapy|May 17, 2024
Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal CancerPim J J Damen, Peter S N van Rossum, Yiqing Chen, et al.
Clinical Lung Cancer|December 4, 2014
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiationCameron W Swanick, Steven H Lin, Jordan Sutton, et al.
Practical Radiation Oncology|August 2, 2019
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment NomogramPeter S N van Rossum, Wei Deng, David M Routman, et al.
Cureus|January 17, 2019
Active Surveillance for Medically Inoperable Stage IA Lung Cancer in the ElderlyHyunsoo J No, Nataniel H Lester-Coll, David J Seward, et al.
Practical Radiation Oncology|September 18, 2016
Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractionsCameron W Swanick, Pamela K Allen, Randa Tao, et al.
Pageof 33

Showing results (171-180 of 328) with videos related to

Sort By:
Pageof 33
Annals of Surgical Oncology|March 24, 2018
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal AdenocarcinomaLucas Goense, Peter S N van Rossum, Mian Xi, et al.
Translational Lung Cancer Research|February 10, 2023
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancerEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation TherapyXin Wang, Peter S N van Rossum, Yan Chu, et al.
Cancer Immunology Research|June 13, 2019
An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune ResponsesIsmail M Meraz, Mourad Majidi, Feng Meng, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2013
Predictors of postoperative complications after trimodality therapy for esophageal cancerJingya Wang, Caimiao Wei, Susan L Tucker, et al.
International Journal of Particle Therapy|May 17, 2024
Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal CancerPim J J Damen, Peter S N van Rossum, Yiqing Chen, et al.
Clinical Lung Cancer|December 4, 2014
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiationCameron W Swanick, Steven H Lin, Jordan Sutton, et al.
Practical Radiation Oncology|August 2, 2019
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment NomogramPeter S N van Rossum, Wei Deng, David M Routman, et al.
Cureus|January 17, 2019
Active Surveillance for Medically Inoperable Stage IA Lung Cancer in the ElderlyHyunsoo J No, Nataniel H Lester-Coll, David J Seward, et al.
Practical Radiation Oncology|September 18, 2016
Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractionsCameron W Swanick, Pamela K Allen, Randa Tao, et al.
Pageof 33